ABSTRACT
Photodynamic therapy (PDT) is currently approved for commercialization worldwide for various cancers (lung, esophagus) and for AMD.
PDT requires a drug (photosensitizer), light corresponding to an absorption band of the photosensitizer, and endogenous oxygen. The absence of any of these agents precludes the photodynamic effect.
